Clinical Trial Update: ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating indocyanine green–based fluorescence imaging to localize prostate cancer and metastatic lymph nodes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Indocyanine Green (ICG) (indocyanine green)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Prostate Cancer | Phase 1 | Status: UNKNOWN